Cadmium burden is associated with increased mortality from influenza or pneumonia in US adults.
Investigators quantified the risk of antenatal influenza and examined its association with perinatal outcomes.
Study authors evaluated the performance of symptom-based definitions to detect influenza in a cohort of pregnant women in India, Peru, and Thailand.
Researchers investigated the effects of ILI on pneumococcal carriage in community-dwelling older adults.
Researchers assessed whether pre-existing antibodies to influenza, which are shaped by early infection and subsequent exposures, impact children’s responses to influenza vaccination.
The approval was supported by data from the randomized, double-blind, placebo-controlled phase 3 Blockstone trial.
Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.
Researchers conducted a retrospective cohort study to compare characteristics of children with a confirmed diagnosis of COVID-19, seasonal influenza A, and influenza B.
Researchers linked the use of 2 hypertension drug classes to lower mortality for those hospitalized with flu and pneumonia.
Investigators conducted a randomized, open-label trial during the 2018-2019 influenza season to assess neutralization titers in pre- and post-immunization sera from 133 adults immunized with one of three types of influenza vaccines.
Researchers evaluated prevalence of and sociodemographic disparities in influenza vaccination among individuals with ASCVD.
Flu shots may be more important than ever this year, as COVID-19 presents new challenges for clinicians and communities this flu season.
There was very low influenza activity during June to August 2020 in the Southern Hemisphere.
Fetal exposure to the H1N1 vaccine is not associated with an increased risk for autism spectrum disorder or autistic disorder in children.
The rate of acute cardiovascular events was found to be high in adults hospitalized with influenza.
For patients with heart failure, influenza and pneumococcal vaccinations are associated with lower in-hospital mortality.
During the upcoming flu season, it is essential to ensure a high coverage rate of vaccination, particularly among populations who are vulnerable to COVID-19.
The efficacy and safety of pimodivir, an inhibitor of influenza virus polymerase basic protein 2, was being investigated in two phase 3 studies.
Influenza vaccination should occur by the end of October, if possible.
The pulmonary pathobiology of patients who died from respiratory failure caused by COVID-19 vs influenza was found to be distinct.